Evidence map›Paper›PMID 33014954›Full record

ArticleFrontiers in public health2020

Communicable Diseases (Including COVID-19)-Induced Global Depression: Caused by Inadequate Healthcare Expenditures, Population Density, and Mass Panic.

Muhammad Khalid Anser, Zahid Yousaf, Muhammad Azhar Khan, Abdullah Zafar Sheikh, Abdelmohsen A Nassani, Muhammad Moinuddin Qazi Abro, Khalid Zaman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Cost-effectiveness of plasmapheresis and hemoperfusion in COVID-19 survivors: A six-month follow-up analysis after hospital discharge.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Does COVID-19 pandemic disrupt sustainable supply chain process? Covering some new global facts.Environmental science and pollution research international · 2021
    Article
  6. Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.Environmental science and pollution research international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Muhammad Khalid AnserSchool of Public Administration, X'an University of Architecture and Technology, Xi'an, China.
Zahid YousafHigher Education Department Khyber Pakhtunkhwa, Government College of Management Sciences, Abbottabad, Pakistan.
Muhammad Azhar KhanDepartment of Economics, University of Haripur, Haripur, Pakistan.
Abdullah Zafar SheikhFaculty of Business Administration, Institute of Business Administration, Karachi, Pakistan.
Abdelmohsen A NassaniDepartment of Management, College of Business Administration, King Saud University, Riyadh, Saudi Arabia.
Muhammad Moinuddin Qazi AbroDepartment of Management, College of Business Administration, King Saud University, Riyadh, Saudi Arabia.
Khalid ZamanDepartment of Economics, University of Haripur, Haripur, Pakistan.
University of Haripur · PKGovernment of Khyber Pakhtunkhwa · PKInstitute of Business Administration Karachi · PKKing Saud University · SAUniversity of Business and Technology · SAXi'an University of Architecture and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus (COVID-19) is spreading at an enormous rate and has caused deaths beyond expectations due to a variety of reasons. These include: (i) inadequate healthcare spending causing, for instance, a shortage of protective equipment, testing swabs, masks, surgical gloves, gowns, etc.; (ii) a high population density that causes close physical contact among community members who reside in compact places, hence they are more likely to be exposed to communicable diseases, including coronavirus; and (iii) mass panic due to the fear of experiencing the loss of loved ones, lockdown, and shortage of food. In a given scenario, the study focused on the following key variables: communicable diseases, healthcare expenditures, population density, poverty, economic growth, and COVID-19 dummy variable in a panel of 76 selected countries from 2010 through 2019. The results show that the impact of communicable diseases on economic growth is positive because the infected countries get a reap of economic benefits from other countries in the form of healthcare technologies, knowledge transfers, cash transfers, international loans, aid, etc., to get rid of the diseases. However, the case is different with COVID-19 as it has seized the whole world together in a much shorter period of time and no other countries are able to help others in terms of funding loans, healthcare facilities, or technology transfers. Thus, the impact of COVID-19 in the given study is negatively impacting countries' economic growth that converts into a global depression. The high incidence of poverty and social closeness increases more vulnerable conditions that spread coronavirus across countries. The momentous increase in healthcare expenditures put a burden on countries' national healthcare bills that stretch the depression phase-out of the boundary. The forecasting relationship suggested the negative impact of the coronavirus pandemic on the global economy would last the next 10 years. Unified global healthcare policies, physical distancing, smart lockdowns, and meeting food challenges are largely required to combat the coronavirus pandemic and escape from global depression.

Indexed as

Communicable DiseasesCOVID-19Communicable Disease ControlDelivery of Health CareDepressionHealth ExpendituresHumansPopulation DensitySARS-CoV-2communicable diseases(COVID-19)global depressionGMM estimatorhealthcare expenditurespopulation densitypoverty incidence

Identifiers

PMID33014954
PMCPMC7461953
OpenAlexW3060024825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.